Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
3,621 total articles
Kevin Maddock, Executive Vice President and Chief Recurring Revenue Officer at Rimini Street, Inc. (NASDAQ:RMNI), was involved in automatic sell-to-cover stock sales on March 4, 2026, while simultaneously acquiring additional shares through the exercise of equity units. Separately, Rimini Street extended its ERP support engagement with Tidewater In…
Alclear Investments, LLC, a director and ten percent owner of Clear Secure, Inc. (NASDAQ: YOU), executed a series of transactions in early March 2026 that included the sale of 174,324 Class A shares for roughly $8.4 million and additional disposals and simultaneous acquisitions across Class A, B and D shares. The sales were made under a pre-establi…
Clear Secure CEO Caryn Seidman Becker sold 174,324 shares of Class A Common Stock on March 4, 2026, generating about $8.46 million. The trades took place as the company's stock traded close to its 52-week high and followed a quarter marked by revenue and bookings that beat the high end of guidance. Multiple brokerages raised price targets after the…
CoreWeave Chief Strategy Officer Brian M. Venturo, via West Clay Capital LLC, sold 334,950 Class A shares on March 4, 2026, for roughly $22.3 million under a Rule 10b5-1 plan. The stock has retreated from the sale range to $72.99, while the company reported 2025 revenue of $5.13 billion and announced a strategic partnership for AI inference workloa…
Delek Logistics Partners Executive Vice President Reuven Spiegel sold 250 common units on March 4, 2026, at $53.20 per unit for a total of $13,300. The transaction, executed under a pre-arranged 10b5-1 trading plan adopted March 6, 2025, leaves Spiegel with 22,490 common units. The company recently reported fourth-quarter 2025 results that fell sho…
Delek US Holdings Executive Vice President Israel Joseph sold 38,000 shares on March 4, 2026, generating $1.54 million at a weighted average price of $40.65. The company recently reported a strong adjusted EPS beat for Q4 2025 but missed revenue expectations. Shares trade near a 52-week high, while third-party analysis flags potential overvaluation…
Director Yemin Ezra Uzi executed sales of Delek US Holdings, Inc. (NASDAQ: DK) common stock on March 4, 2026, disposing of 84,650 shares across direct and indirect holdings for a combined $3,654,340. The transactions were carried out under a 10b5-1 trading plan adopted December 3, 2025. The insider sale follows a more-than-209% run-up in the stock …
Delek US Holdings Executive Vice President for Special Projects, Reuven Spiegel, sold 20,000 shares on March 4, 2026, generating $856,800 at a weighted average price of $42.84, according to a Form 4 filing. The transaction occurred while the stock traded at $42.29, close to a 52-week peak and following notable returns over the past year. Company re…
Delek US Holdings director Zohar Shlomo sold 29,372 shares of the company's common stock under a pre-arranged 10b5-1 plan between March 4 and March 5, 2026, generating $1,303,382 in proceeds at prices between $43.00 and $45.50 per share. The transactions follow a year of significant share appreciation and come alongside the company's mixed fourth-q…
Robert Ainscow, chief operating officer of ASP Isotopes Inc. (NASDAQ:ASPI), sold 8,438 shares on March 6, 2026, at a weighted average price of $5.439 for proceeds of $45,894 to satisfy tax withholding obligations. The transaction occurred while the stock has fallen 32% over six months and trades near $5.55. Separately, ASP completed its acquisition…
A Delek US Holdings, Inc. director sold 5,392 shares on March 4, 2026, generating proceeds of $230,508. The sale comes while the stock trades close to its 52-week high after a 209% gain over the past year. Separately, Delek reported a sizable adjusted EPS beat for Q4 2025 but missed revenue expectations.
Rimini Street (RMNI) disclosed that CEO Ravin Seth A. sold 52,085 shares on March 4, 2026, in automatic sell-to-cover transactions tied to tax withholding obligations related to RSU and Performance Unit vesting. The filing also shows conversions of 125,286 restricted units into common stock, an acquisition of the same number of shares at $0, and a …
Peter McCann, senior vice president for Australia at Civeo Corp, disposed of 4,000 common shares on March 6, 2026, generating $114,560 at a weighted average price of $28.64. The trade occurred while CVEO traded close to its 52-week peak and following a quarterly report that missed earnings and revenue expectations but showed year-over-year revenue …
James E. Newsome, a director at Cipher Digital Inc (NASDAQ:CIFR), sold 45,161 shares on March 4, 2026, generating roughly $710,834. The share sale occurred across multiple trades at prices between $15.74 and $15.76. After the transactions Newsome directly held 127,331 shares. Cipher Digital's stock has fallen to $13.63 after a year-to-date rise of …
Rimini Street Executive Vice President and Chief Marketing Officer David W. Rowe completed an automatically-triggered sale of 7,209 Rimini Street shares on March 4, 2026 to satisfy withholding tax obligations tied to equity vesting. The transaction, executed at $3.6428 per share and totaling $26,260, coincided with the vesting of Restricted Stock U…
Rimini Street Executive Vice President and Chief Financial Officer Michael L. Perica executed a stock sale on March 4, 2026 to satisfy withholding tax obligations connected to vesting equity awards. The sale of 24,879 shares at $3.6428 generated roughly $90,629 in proceeds. On the same day Perica received vested Restricted Stock Units and Performan…
Rimini Street Executive Vice President and Chief Client Officer Nancy Lyskawa completed an automatic sale of 5,337 shares of Rimini Street common stock on March 4, 2026, to satisfy withholding tax obligations tied to the vesting of restricted stock and performance units. On the same day she exercised options to acquire 17,125 shares through the con…
AIPCT Holdings LLC and AIPCT Intermediate Holdings I LLC sold 3,041,288 shares of Titan International Inc. (NYSE: TWI) on March 4, 2026, at $8.95 per share, generating $27,219,527 in proceeds. The sale occurred amid recent share weakness and follows the company's mixed fourth-quarter 2025 report and guidance that disappointed investors.
Unity Software CFO Yahes Jarrod sold 6,205 shares on March 5, 2026, in a transaction totaling $130,491 to satisfy tax withholding tied to restricted stock unit vesting. The trade was non-discretionary. The move arrives amid pronounced stock volatility, a recent quarter that exceeded revenue and EBITDA expectations, and reports that Unity is explori…
Lisa A. Nalley, BrightSpring Health Services' Chief of Staff and SVP of Human Resources, sold 30,000 shares of company stock on March 4, 2026, generating roughly $1.23 million. The transactions, disclosed via an SEC Form 4, included option exercises and subsequent equity grants. The stock has climbed sharply over the past year and sits close to its…
Innospec director Milton C. Blackmore sold 594 shares of the company's common stock on February 27, 2026, in two transactions totaling approximately $45,472. The trades were executed at prices of $76.30 and $76.79. After the sales, Blackmore directly holds 10,530 shares. The company’s share price is trading near its 52-week low, while InvestingPro’…
QuantumScape Chief Technology Officer Timothy Holme sold a total of 127,077 shares of Class A Common Stock on March 5, 2026, generating about $1.1 million at a weighted average price of $6.8646. The transactions, disclosed in a Form 4 filing with the Securities and Exchange Commission, occurred in multiple tranches at prices between $6.715 and $6.9…
Director Lawrence Sandra AJ sold 1,560 shares of Sera Prognostics, Inc. (SERA) Class A common stock on March 6, 2026, for a total of $3,042 under a Rule 10b5-1 plan. The trade occurred as the stock traded around $1.95, roughly 15% lower over the prior week and near a 52-week low. Separately, a large clinical trial of the company's PreTRM Test invol…
Bicara Therapeutics Chief Executive Officer Claire Mazumdar sold 8,234 shares of common stock between March 4 and March 6, 2026, for roughly $154,324 at weighted average prices of $18.7338 to $18.7508. The transactions followed her exercise of options to acquire the same number of shares at $3.7898 per share. After the sales and exercise, Mazumdar …
David M. Carter, president of Kratos’ DRSS Division, executed a sale of 3,000 shares of company common stock on March 5, 2026, netting approximately $341,422. The transactions followed a March 4 settlement of 15,000 performance restricted stock unit awards, with 9,168 shares withheld for taxes. Separately, Kratos announced a $7 million Counter-UAS …
